Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Alnylam Reports Positive Results for Nanotech-Enabled RNAi Therapeutic Targeting PCSK9
AZ Nano
Saturday, January 7, 2012 - 2:07pm
tags:
Tekmira Pharmaceuticals, Alnylam, ALN-PCS
Jazz Pharmaceuticals Inc Stock Getting Overbought (JAZZ)
Market News Video
Saturday, January 7, 2012 - 1:37pm
tags:
Jazz Pharmaceuticals
Valeant expects $200 million in savings in 2012
Toronto Star, Canada
Saturday, January 7, 2012 - 1:36pm
tags:
Valeant Pharmaceuticals
Endo Pharmaceuticals to Pay $180M in a Licensing and Development Agreement for BioDelivery Sciences International Pain Treatment
Becker's Orthopedic and Spine
Saturday, January 7, 2012 - 1:35pm
tags:
BioDelivery Sciences, Endo, pain management, buprenorphine
Jazz Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Saturday, January 7, 2012 - 1:33pm
tags:
Jazz Pharmaceuticals
Cramer Backs Alexion Stock
CNBC
Saturday, January 7, 2012 - 1:31pm
tags:
Alexion
Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Pacific Biosciences of California, Inc.
Yahoo/BusinessWire
Saturday, January 7, 2012 - 1:30pm
tags:
Pacific Biosciences, lawsuits
Dendreon, JAZZ and Regeneron Among Best Stock Price Performers
Yahoo/Wall St. Cheat Sheet
Saturday, January 7, 2012 - 1:26pm
tags:
Dendreon, Jazz, Regeneron
Astellas and Theravance Announce Termination of License, Development and Commercialization Agreement for Vibativ (telavancin) for Injection
Yahoo/MarketWire
Saturday, January 7, 2012 - 1:25pm
tags:
Theravance, Astellas, Vibativ, antibiotics
Gilead Sciences Announces Early Termination of Hart-Scott-Rodino Waiting Period
Yahoo/BusinessWire
Saturday, January 7, 2012 - 1:23pm
tags:
Gilead Sciences, Pharmasset, M&A
Questcor Pharmaceuticals Reports Strong Finish to 2011
Yahoo/PR NewsWire
Saturday, January 7, 2012 - 1:22pm
tags:
Questcor Pharmaceuticals, Acthar
Dendreon: Provenge Sales Surprise On Upside, Bodes Well For The Stock
Seeking Alpha
Saturday, January 7, 2012 - 1:20pm
tags:
Dendreon, Provenge
ViroPharma Expects a Strong 2012
Yahoo/Zacks
Saturday, January 7, 2012 - 1:15pm
tags:
ViroPharma
Pharmaceutical Stocks with Fantastic Valuations and Dividend Yield
Motley Fool
Saturday, January 7, 2012 - 1:14pm
tags:
Pfizer, Merck
Abbott Laboratories Dividend Capture With Options
Seeking Alpha
Saturday, January 7, 2012 - 1:11pm
tags:
Abbott Laboratories
Aegerion Pharmaceuticals Announces Lomitapide 78-Week Phase III Clinical Data Consistent With Earlier Results
Yahoo/Globe NewsWire
Saturday, January 7, 2012 - 12:42pm
tags:
Aegerion, lomitapide, hypercholesterolemia
ViroPharma Expects a Strong 2012
Yahoo/Zacks
Friday, January 6, 2012 - 6:10pm
tags:
ViroPharma
Abbott Laboratories Dividend Capture With Options
Seeking Alpha
Friday, January 6, 2012 - 6:07pm
tags:
dividends, Abbott Laboratories
Amgen, big biotechs poised for big year of deals, analysts say
Fierce Pharma
Friday, January 6, 2012 - 1:37pm
tags:
Amgen, biotech, M&A, Celgene
Myth Versus Reality: Promoting A Pricey Gout Pill
Pharmalot
Friday, January 6, 2012 - 1:36pm
tags:
gout, Colcrys, URL Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.